Stock DERM JOURNEY MEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Journey Medical Corporation

Equities

DERM

US48115J1097

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.4 USD -2.86% Intraday chart for Journey Medical Corporation -2.30% -40.97%
Mar. 21 Transcript : Journey Medical Corporation, 2023 Earnings Call, Mar 21, 2024
Mar. 21 Journey Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Journey Medical Corporation

Price target over the last 5 years

History of analyst recommendation changes

ff.IZzuYZpvSgwiAeIsmJjZdksi4NsvlZVXRC1DcPjEmOQ.QM7dMdkoezpFbZNJx7WSLBFBtrFZ9vohKWFyAqKi1tZmsaQioxl9R0Fu2g~c528fd9af81ea73fff6aa902e8c9bea8

Analyst Recommendations on Journey Medical Corporation

Alliance Global Partners Starts Coverage on Journey Medical With Buy Rating, $8.50 Price Target MT
B. Riley Lifts Journey Medical's PT to $8 From $6 After US FDA Gives Green Light for DFD-29's Year-End 2023 Filing, Keeps Buy Rating MT
B. Riley Raises Journey Medical's PT to $6 From $3 On 'Impressive' Results From DFD-29 Study in Moderate to Severe Papulopustular Rosacea, Keeps Buy Rating MT
B. Riley Cuts Journey Medical's Price Target to $3 From $6, Keeps Buy Rating MT
B. Riley Lowers Journey Medical's Price Target to $6 From $10 After Q3 Topline Miss on Generic Competition, Keeps Buy Rating MT
B. Riley Lowers Journey Medical's Price Target to $10 from $14, Keeps Buy Rating MT
Cantor Fitzgerald Reinstates Journey Medical at Overweight with $9 Price Target MT
Roth Capital Starts Journey Medical at Buy With $15 Price Target MT
B. Riley Starts Journey Medical at Buy with $14 PT, Says Well-Positioned for Revenue, Earnings Growth MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.4 USD
Average target price
8.25 USD
Spread / Average Target
+142.65%
High Price Target
8.5 USD
Spread / Highest target
+150.00%
Low Price Target
8 USD
Spread / Lowest Target
+135.29%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Journey Medical Corporation

Alliance Global Partners
B. Riley
Cantor Fitzgerald
Roth Capital Partners

Ratings for Journey Medical Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. DERM Stock
  4. Consensus Journey Medical Corporation